Glenmark Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '23
Sep '23
Jun '23
Mar '23
Dec '22
Total Qtr Revenue cr
2,552.11
3,209.08
3,422.48
3,333.50
3,540.27
Other Income Qtr Cr45.411.7020.87-40.2176.42
Operating Revenues Qtr2,506.703,207.383,401.603,373.723,463.86

*All values are in Cr.

Operating Expenses Qtr
2,715.35
2,745.09
2,770.39
2,768.75
2,843.61
Operating Profit Qtr
-208.65
462.29
631.21
604.97
620.24
EBIDT Qtr Cr
-121.20
257.30
600.06
-234.98
730.54
Depreciation Qtr
147.08
141.45
154.65
146.53
162.28
Net Profit Qtr
-351.38
-81.95
23.19
-428.30
290.76
Basic EPS Qtr
-12.45
-2.90
5.31
-15.18
9.66
Open Demat Account
or Resume your Application
+91 -

personImage